Abstract
Results from four consecutive trials, conducted from 1982 by members of the Scandinavian Sarcoma Group, are reviewed. A total of 330 classical osteosarcoma patients were enrolled. In all trials chemotherapy was based on the three active drugs, methotrexate, doxorubicin and cisplatinum and for the latter trials also ifosfamide. Post-operative chemotherapy was stratified by histological response to up-front treatment. © 2010 Springer Science+Business Media, LLC.
Cite
CITATION STYLE
Bruland, Ø. S., Bauer, H., Alvegaard, T., & Smeland, S. (2009). Treatment of osteosarcoma. The Scandinavian Sarcoma Group experience. In Cancer Treatment and Research (Vol. 152, pp. 309–318). https://doi.org/10.1007/978-1-4419-0284-9_16
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
